Education
About Us
Working with TipRanks
Follow Us
Erasca (ERAS)
NASDAQ:ERAS
Eras-4001, Eras-4001 In Combination
Metastatic Solid Tumors
Phase I
Recruiting
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Jun 06, 2025
―
Eras-0015, Eras-0015 In Combination
Metastatic Solid Tumors
Phase I
Recruiting
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
May 14, 2025
―
Temozolomide, Trametinib, Dacarbazine, Naporafenib
Advanced Or Metastatic Nras-Mutant Melanoma
Phase III
Recruiting
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
Mar 17, 2024
―
Trametinib, Naporafenib
Advanced Or Metastatic Solid Tumors
Phase I
Active Not Recruiting
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
May 30, 2023
―
Eras-801
Glioblastoma Multiforme
Phase I
Active Not Recruiting
A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
Jan 24, 2022
―
Encorafenib, Palbociclib, Cetuximab, Eras-007
Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma
Phase I/II
Active Not Recruiting
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Sep 01, 2021
―
Pembrolizumab, Cetuximab, Eras-601
Advanced Or Metastatic Solid Tumors
Phase I
Active Not Recruiting
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Dec 11, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Erasca (ERAS) have in its pipeline
ERAS is currently developing the following drugs: Eras-4001, Eras-4001 In Combination, Eras-0015, Eras-0015 In Combination, Temozolomide, Trametinib, Dacarbazine, Naporafenib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.